Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vietnam Delays GMP Compliance For Two More Years

This article was originally published in PharmAsia News

Executive Summary

Vietnam has decided to put off Good Manufacturing Practices requirements until 2010 instead of ordering them this month as planned. The Ministry of Health acted after pharmaceutical industry representatives appealed for more time because of the high cost many face in having to comply with the GMP standards. The head of Central 2 Pharmaceutical, which is compliant, said it had to spend $7 million over two years to change its factory and production line to meet the standards. He said many other companies would have great difficulty in raising the money needed to comply. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069227

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel